Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide in inflammatory bowel disease.

Raymond K Cross1, Keith T Wilson

  • 1Department of Medicine, Division of Gastroenterology, University of Maryland School of Medicine, Baltimore 21201, USA.

Inflammatory Bowel Diseases
|June 7, 2003
PubMed
Summary

Inducible nitric oxide synthase (iNOS) is upregulated in inflammatory bowel disease (IBD). While iNOS inhibition may help, its role in IBD pathogenesis remains complex and warrants further investigation into competing pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreatic islet α cell function and proliferation require the arginine transporter SLC7A2.

The Journal of clinical investigation·2026
Same author

Regulation of EIF5A and hypusination by p53 determines colorectal cancer cell fitness.

Cancer letters·2026
Same author

Safety of biologics and Janus kinase inhibitors in inflammatory bowel disease patients with low cardiovascular risk.

Crohn's & colitis 360·2026
Same author

Treatment outcomes of prolonged induction or re-escalation dosing of upadacitinib in patients with inflammatory bowel disease.

Crohn's & colitis 360·2026
Same author

Impact of mirikizumab on patient-reported outcomes and quality of life in patients with Crohn's disease: results from the phase 2 SERENITY study.

Crohn's & colitis 360·2026
Same author

Non-invasive determination of disease activity in Crohn's disease by serum luminex profiling.

Scientific reports·2026

Area of Science:

  • Gastroenterology
  • Immunology
  • Biochemistry

Background:

  • Nitric oxide (NO) acts as a messenger molecule.
  • Inducible nitric oxide synthase (iNOS) produces NO and is upregulated in mucosal inflammation.
  • Increased iNOS expression, activity, and NO are observed in inflammatory bowel disease (IBD) tissues.

Purpose of the Study:

  • To review the evidence for iNOS involvement in IBD.
  • To explore the complex and sometimes contradictory findings regarding iNOS inhibition and deficiency in IBD models.
  • To highlight the need for further research into alternative metabolic pathways.

Main Methods:

  • Review of existing literature on iNOS in IBD.
  • Analysis of studies involving iNOS inhibition in animal models.
  • Examination of data from iNOS-deficient mice in colitis models.

Main Results:

  • iNOS is upregulated in human IBD tissues.
  • iNOS-derived NO levels correlate with disease activity in ulcerative colitis, but variably in Crohn's disease.
  • Animal studies show mixed results for iNOS inhibition and deficiency, with reports of both improvement and exacerbation of experimental IBD.

Conclusions:

  • The role of iNOS in IBD pathogenesis is complex and not fully elucidated.
  • Further research is needed to understand the regulation of mucosal inflammation in IBD.
  • Investigating the competing pathway of l-arginine conversion to polyamines may offer new insights.

Related Experiment Videos